Showing 21 - 40 results of 72 for search '"Botulinum toxin"', query time: 0.07s Refine Results
  1. 21

    Efficacy and Safety of Botulinum Toxin Type A in Treating Patients of Advanced Age with Idiopathic Trigeminal Neuralgia by Jing Liu, Ying-Ying Xu, Qi-Lin Zhang, Wei-Feng Luo

    Published 2018-01-01
    “…To assess the therapeutic efficacy and safety of botulinum toxin type A (BTX-A) for treating idiopathic trigeminal neuralgia (ITN) in patients ≥80 years old. …”
    Get full text
    Article
  2. 22
  3. 23

    Injection of Botulinum Toxin a to Upper Esophageal Sphincter for Oropharyngeal Dysphagia in Two Patients with Inclusion Body Myositis by Louis WC Liu, Mark Tarnopolsky, David Armstrong

    Published 2004-01-01
    “…Surgical cricopharyngeal myotomy may be effective for cricopharyngeal dysphagia and there is one published report that botulinum toxin A, injected into the cricopharyngeus muscle using a hypopharyngoscope under general anesthesia, relieved IBM-associated dysphagia. …”
    Get full text
    Article
  4. 24

    An Experimental Study on Botulinum Toxin Type A for the Treatment of Excessive Secretion after Submandibular Gland Transplantation in Rabbits by Shang Xie, Hui Xu, Bo Lin, Kan Wang, Xiao-Feng Shan, Zhi-Gang Cai

    Published 2016-01-01
    “…To investigate whether botulinum toxin type A (BTXA) could control excessive secretion after submandibular gland (SMG) transplantation in rabbits and its possible mechanisms. …”
    Get full text
    Article
  5. 25
  6. 26

    Split-face intradermal botulinum toxin versus saline injection for facial aging: a single-center study by Hala M. Elbasiony, Nashwa N. Elfar, Shereen F. Gheida, Noha N. Doghim

    Published 2024-01-01
    “…The most popular non-surgical one is Botulinum toxin A which inhibits Acetylcholine release at neuromuscular junctions then leads to facial muscle relaxation. …”
    Get full text
    Article
  7. 27

    Botulinum toxin type A for the treatment of patients with post-stroke spasticity in Thailand: cost-utility and budget impact analysis by Phorntida Hadnorntun, Pattara Leelahavarong, Tanawan Kongmalai, Varalak Srinonprasert, Juthamas Prawjaeng, Phakamas Tanvijit, Chuenchom Chueluecha, Nawarat Jintakul, Tipyarat Saringcarinkul, Witsanu Kumthornthip

    Published 2025-01-01
    “…Objectives To evaluate the cost-utility of botulinum toxin A (BoNT-A) for treating upper limb (UL) and lower limb (LL) post-stroke spasticity.Design Using a Markov model, adopting a societal perspective and a lifetime horizon with a 3% annual discount rate, the cost-utility analysis was conducted to compare BoNT-A combined with standard of care (SoC) with SoC alone. …”
    Get full text
    Article
  8. 28

    Quantitative Effects on Proximal Joints of Botulinum Toxin Treatment for Gastrocnemius Spasticity: A 4-Year-Old Case Study by Veronica Cimolin, Manuela Galli, Marcello Crivellini, Giorgio Albertini

    Published 2009-01-01
    “…Botulinum toxin A (BTA) is a recognized treatment for the early management of spasticity in children with Cerebral Palsy. …”
    Get full text
    Article
  9. 29
  10. 30

    Long‐term follow‐up of intradetrusor botulinum toxin utilisation: A comparison of patients with multiple sclerosis and idiopathic overactive bladder by William Chui, Joshua Kealey, Henry H. Yao, Garson Chan, Alvaro Bazo, Richard Parkinson, Helen E. O'Connell, Johan Gani

    Published 2025-01-01
    “…Abstract Objectives To assess long‐term outcomes (up to 10 cycles) of repeated intradetrusor botulinum toxin (BoNT) utilisation in multiple sclerosis (MS) and idiopathic overactive bladder (OAB). …”
    Get full text
    Article
  11. 31
  12. 32

    Treatment Efficacy of Electromyography versus Fiberscopy-Guided Botulinum Toxin Injection in Adductor Spasmodic Dysphonia Patients: A Prospective Comparative Study by Jae Wook Kim, Jae Hong Park, Ki Nam Park, Seung Won Lee

    Published 2014-01-01
    “…This study prospectively evaluates and compares the treatment efficacy of botulinum toxin injection under electromyography guidance (EMG group) and percutaneous botulinum toxin injection under flexible fiberscopic guidance (fiberscopy group). …”
    Get full text
    Article
  13. 33

    Hemifacial Spasm due to Compression of the Posterior Inferior Cerebellar Artery Aneurysm Treated with Botulinum Toxin Type-A: A Case Report by Azize Esra Gürsoy, Gülsen Babacan Yildiz, Adam Mehmet Gülhan, Mehmet Kolukisa

    Published 2012-01-01
    “…The patient was treated with Botulinum toxin type A and almost total relief of symptoms was noticed during one month followup. …”
    Get full text
    Article
  14. 34
  15. 35
  16. 36
  17. 37
  18. 38
  19. 39
  20. 40